Sorafenib for the treatment of advanced hepatocellular carcinoma

Por M Connock, J Round, S Bayliss, S Tubeuf, W Greenheld, D Moore
Publicado em 2010-05-01

Cetuximab for the first-line treatment of metastatic colorectal cancer

Por C Meads, J Round, S Tubeuf, D Moore, M Pennant, S Bayliss, C McCabe
Publicado em 2010-05-01

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis

Por M Connock, S Tubeuf, K Malottki, A Uthman, J Round, S Bayliss, C Meads, D Moore
Publicado em 2010-10-01

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia

Por R Edlin, M Connock, S Tubeuf, J Round, A Fry-Smith, C Hyde, W Greenheld
Publicado em 2010-05-01

Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours

Por J Dretzke, J Round, M Connock, S Tubeuf, M Pennant, A Fry-Smith, C Hulme, C McCabe, C Meads
Publicado em 2010-10-01

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease

Por J Dretzke, R Edlin, J Round, M Connock, C Hulme, J Czeczot, A Fry-Smith, C McCabe, C Meads
Publicado em 2011-02-01